The definitions in RCW 69.48.020 apply to this chapter unless the context clearly indicates otherwise.

(1) Upon review of an inquiry response letter described in RCW 69.48.040(3), the department shall notify the person or entity in writing whether or not the person or entity is considered a covered manufacturer. If the department determines that the person or entity is a covered manufacturer, the written notice will include a warning regarding the penalties for violation of this chapter, as authorized in RCW 69.48.110(2).

(2)(a) Within thirty days after the first full year of a drug take-back program's implementation, and annually thereafter, the department may provide a list of covered manufacturers potentially not participating in a drug take-back program to each approved program operator.

(b) Within thirty days of receiving such a list, approved program operators may provide any comments on the list to the department.

(c) Within thirty days of receiving and considering any approved program operator comments, the department may publish on its website a list of all covered manufacturers not participating in a drug take-back program.

(3) The department shall remove any covered manufacturer identified in the published list if the covered manufacturer participates in an approved drug take-back program.

In addition to this section, the drug take-back proposal must comply with chapter 69.48 RCW. Each proposal must be on a form provided by the department and must:

(1) Contain a table of contents clearly denoting, at a minimum, where each component specified in RCW 69.48.050 is located within the program proposal;

(2) Provide a description of a drug collection system that includes:

(a) A list of participating authorized collectors;

(b) A list of drop-off (kiosk) locations; and

(c) A detailed description of how mail-back distribution locations or periodic collection events will be used.

(3) Demonstrate that the policies and procedures to be followed by persons handling unwanted covered drugs collected under the drug take-back program as required in RCW 69.48.050 (2)(f) includes:

(a) How all entities participating in the drug take-back program will operate under all applicable federal and state laws and rules including, but not limited to, United States Drug Enforcement Administration rules; and

(b) How any pharmacy collection sites will operate under applicable rules from the Washington state pharmacy quality assurance commission.

(4) Include a detailed description of the geographical distribution of collection sites that will provide equitable and reasonably convenient access to all residents consistent with RCW 69.48.060;

(5) Include a budget estimate for providing the statewide program. Estimates must show total costs for each of the categories described in this subsection and a sum total of all program costs representing the totals for each category:

(a) Category 1: Administrative costs. A total for all administrative costs must include, but is not limited to:

(i) Contracted and employed personnel overhead costs;

(ii) Legal fees;

(iii) Local and state business licensing fees;

(iv) Local, state, and federal taxes;

(v) Property costs, including rentals;

(vi) Utilities, phone, and internet; and

(vii) General equipment and supplies.

(b) Category 2: Collection and disposal costs. A total for all collection and disposal costs must include, but is not limited to:

(i) Collection, transportation, and disposal of drugs;

(ii) Purchase, maintenance, and replacement of collection receptacles;

(iii) Compensation of authorized collectors, if separate from personnel costs in (a)(i) of this subsection; and

(iv) Production, distribution, and postage of mailers.

(c) Category 3: Communication costs. A total for all communication costs must include, but is not limited to:

(i) Advertising;

(ii) Marketing;

(iii) Website creation and maintenance; and

(iv) Operation of a toll-free phone number.

(6) Describe how the program operator will work with Washington state counties and the department to incorporate local programs into their proposed statewide plan consistent with RCW 69.48.160 (1)(b); and

(7) Include an implementation plan and schedule for initiating operation of the approved drug take-back program.

(1) A potential drug take-back program operator shall submit to the department:

(a) Its proposal to be an approved program in the format provided by the department; and

(b) The proposal review fee in WAC 246-480-990.

(2) An approved drug take-back program operator shall submit to the department:

(a) Any substantial changes to an approved program in the format provided by the department;

(b) The annual operating fee in WAC 246-480-990; and

(c) By July 1, 2024, and every four years thereafter, an updated proposal in the format provided by the department.

(3) If the department takes enforcement action as provided in RCW 69.48.050 (3)(c)(iv), the applicant through its authorized representative may request an adjudicative proceeding under chapter 246-10 WAC. A request for an adjudicative proceeding must be in writing, state the basis for contesting the adverse action, include a copy of the adverse notice and be served on and received by the department within 28 days of the program operator's receipt of the adverse notice. If a request for adjudicative proceeding is not received by the department within 28 days of the date of the program operator's receipt of the adverse notice, the secretary's decision is final.

(1) To assist the program operators in complying with RCW 69.48.060 (3)(c) and (d), the department will determine and locate each population center consistent with RCW 69.48.060 and this chapter using geographical information systems (GIS) mapping technology, and will publish updated population data to the department's website annually.

(2) The department, in consultation with the local health jurisdiction, will determine underserved areas described in RCW 69.48.060(3) using the following criteria:

(a) Population density of counties;

(b) Estimated number of participating collection sites;

(c) Travel distances and times;

(d) Accessible public facilities such as libraries, town halls, and police and fire departments; and

(e) Geographic features that may inhibit access to collection locations such as mountains and islands.

(1) Program operators shall coordinate to present a consistent statewide drug take-back system as described in RCW 69.48.050 and 69.48.070.

(2) Each program operator is independently responsible for complying with all requirements of chapter 69.48 RCW and this chapter. Each program operator is responsible for their own promotional material.

(3) Collection sites at long-term care facilities and substance use disorder treatment programs are not available to the general public. Program operators shall exclude these collection sites from public promotional material.

(4) For the purpose of this section:

(a) "Promotional material" means promotion, education, and outreach material about the safe storage and secure collection of covered drugs and includes, but is not limited to: Websites; telephone numbers; secure collection receptacle (kiosk) signage; posters; brochures; mailer instructional inserts; advertising for drug take-back events; media material; and information for authorized collectors, collection sites, mail-back distribution locations, and take-back event partners.

(b) Public promotional material means promotional material focused on increasing understanding and use of safe medication return.

(c) Partner promotional material means promotional material focused on recruiting and educating authorized collectors, collection sites, mail-back distribution locations, and take-back event partners.

(5) Each program operator shall ensure their public promotional materials are easy for people to use and understand. This includes people with limited-English proficiency and people with disabilities including, but not limited to, people who are deaf or blind.

(6) Each program operator shall ensure their public promotional material describes how to access all collection sites, mail-back distribution locations, and take-back events regardless of program operator.

(7) Each program operator shall refer to the statewide drug take-back system as "Safe Medication Return" on all their promotional material. Program operators shall not use any other name to refer to their drug take-back program. Nothing in this section prohibits inclusion of program operator name in or on promotion, education, or outreach material.

(8) Program operators shall coordinate to develop a safe medication return logo or mark and shall use the logo or mark to promote safe medication return as the statewide drug take-back system.

(a) The logo or mark must be approved by the department prior to use by any program operator.

(b) The logo or mark must be included on all promotional material.

(9) Program operators shall ensure the single website required by RCW 69.48.070 presents a consistent statewide drug take-back system.

(a) The single website domain name must be descriptive of safe medication return, Washington's drug take-back system, and must not appear specific to any program operator.

(b) The single website must describe the statewide safe medication return system including, but not limited to, information on:

(i) Why and how to safely store and securely dispose of medication, including discouraging disposal of medication down drains or in the garbage;

(ii) What safe medication return accepts and does not accept; and

(iii) The single toll-free telephone number.

(c) The single website must display all collection sites and mail-back distribution locations available to the general public for all program operators on one map and in one table. The single website must display all drug take-back events for all program operators in one table. This information must be searchable by zip code and city and must display all options regardless of program operator.

(d) Each program operator shall update their collection sites, mail-back distribution locations, and locations and dates for drug take-back events on the single website at least quarterly.

(e) The single website must include, in a prominent place, links to the department's safe medication return website and contact information. The single website must inform the public that the department welcomes comments, questions, and concerns. The department shall provide program operators the appropriate URL and contact information.

(10) Program operator specific websites must present a consistent statewide drug take-back system.

(a) Program operator specific websites must include links to the single website described in subsection (9) of this section.

(b) Program operator specific websites must present all collection sites, mail-back distribution locations, and take-back events for all program operators whenever presenting information about any collection site, mail-back distribution location, or take-back event. Information about other program operator's collection sites, mail-back distribution locations, and take-back events must be at least as current as single website.

(c) Program operators shall not include program operator specific websites in any public promotional material.

(11) Program operators may include program operator specific email address on secure collection receptacles (kiosks) and mailer instructional inserts to inform the public how to receive support or provide comments about secure collection receptacle (kiosk) or mailer. Program operator specific email addresses must not be included on any other public promotional material.

(12) Program operators shall ensure the single toll-free telephone number required by RCW 69.48.070(2) and all call centers accessed through that single toll-free telephone number present a consistent statewide drug take-back system. The single toll-free telephone number and all call centers accessed through it must:

(a) Answer calls 24 hours a day, seven days a week;

(b) Allow callers to access information about the statewide safe medication return system including, but not limited to:

(i) Why and how to safely store and securely dispose of medication, including discouraging disposal of medication down drains or in the garbage;

(ii) What safe medication return accepts and does not accept; and

(iii) The single website.

(c) Provide callers with all collection sites, mail-back distribution locations, and drug take-back events available to the general public for all program operators based on location criteria provided by the caller. Callers shall not be required to choose between program operators to receive this information;

(d) Allow callers to order mail-back supplies; and

(e) Provide the department's contact information to callers who would like to provide feedback, including comments, questions, and concerns. The department shall provide program operators the appropriate contact information.

(13) Program operator specific telephone numbers and call centers must present a consistent statewide drug take-back system.

(a) Program operator specific telephone numbers and call centers must present all collection sites, mail-back distribution locations, and take-back events available to the general public for all program operators whenever presenting information about any collection site, mail-back distribution location, or take-back event.

(b) Program operators shall not include program specific telephone numbers in any public promotional material, except on secure collection receptacles (kiosks) and mailer instructional inserts to inform the public how to receive support and provide comments about secure collection receptacle (kiosk) or mailer.

(14) Current program operators shall coordinate with newly approved program operators to ensure subsections (1), (9), and (12) of this section are met within 180 days of the department's approval of a new program operator's proposal.

(15) Requirements of this section must be implemented by program operators within one year of the date the rule is adopted.

(1) Each program operator shall submit an annual report to the department by July 1st in the format provided by the department.

(2) To ensure consistency of program operator reporting and ensure the department can accurately analyze the data, the annual program report must include:

(a) A list of covered manufacturers participating with the program operator.

(b) The amount, by weight, of covered drugs collected, including the amount by weight from each collection method used.

(c) The list of collection sites with addresses must:

(i) Indicate collection sites added since previous annual report was submitted to the department;

(ii) Also be provided as a map; and

(iii) Identify any retail pharmacy, hospital or clinic with an on-site pharmacy, or law enforcement agency that offered to participate and was not included as an authorized collector within 90 days of the program operator receiving offer.

(A) If potential authorized collector was included later, describe reason for delay.

(B) If potential authorized collector was not included, describe reason for exclusion.

(d) A description of prompt collection, maintenance, and kiosk inner liner supply requests.

(i) Describe whether agreements with collection sites include requirement for collection site to report need for prompt collection, maintenance, or inner liner supplies.

(ii) Describe any instances where program operator identified issues related to collection receptacle (kiosk) not being available to accept covered drugs when collection site was open for business, including issues identified during program operator inspection of receptacles; number of requests for prompt collection, maintenance, or inner liner supplies; and average number of days between request and collection or response.

(iii) Describe any instances where requests for prompt collection, maintenance, or inner liner supplies were not provided by the program operator as described in their approved plan. The description shall include the reason prompt collection, maintenance, or inner liner supplies were not provided and the number of days between request and collection or response.

(e) The number of mailers provided as reported by zip code and must include the number of mailers provided for each of the following categories:

(i) Directly to individuals as the result of requests made through website or toll-free telephone number;

(ii) Directly to households without anyone requesting them;

(iii) To retail pharmacies that are not mail-back distribution locations;

(iv) To other businesses or organizations that are not mail-back distribution locations; and

(v) To mail-back distribution locations.

(f) The locations where mailers were provided and must include a list of:

(i) Zip codes where individuals requested mailers from the single website, single toll-free telephone number, program operator specific website, or program operator specific telephone number;

(ii) Zip codes where households were sent mailers directly without requesting them. This list must indicate the percentage of households per zip codes that were sent mailers;

(iii) Nonresidential locations that are not mail-back distribution locations with addresses; and

(iv) Mail-back distribution locations with addresses.

(g) Dates and locations of collection events held.

(h) A description of collection sites, mail-back distribution locations, take-back events, and other methods for accessing safe medication return in areas outside of population centers.

(i) List all law enforcement, retail pharmacies, and hospitals or clinics with on-site pharmacies on islands and outside population centers and indicate whether they are authorized collectors.

(ii) For each law enforcement facility, retail pharmacy, and hospital or clinic with on-site pharmacy that is not an authorized collector, describe the reason they are not participating. Include recruitment efforts and the result of those efforts.

(i) Transporters and disposal facilities used.

(j) Safety or security problems including, but not limited to, all instances where collection, transportation, or disposal did not follow processes described in the approved plan, including processes for prompt collection and maintenance. Safety and security problems described must include any instances where a secure collection receptacle (kiosk) is opened for a reason other than packaging the inner liner for shipping, installing a new inner liner, or maintenance on a kiosk that does not contain an inner liner. The description of whether safety or security problems occurred during collection, transportation, or disposal of covered drugs must include:

(i) Whether the problem occurred during collection, transportation, or disposal;

(ii) Whether the problem met criteria for reporting to law enforcement, Washington state pharmacy quality assurance commission, United States Drug Enforcement Administration, or other entity and whether the operator can confirm that the reporting happened;

(iii) If covered drugs were lost during transportation, whether transporter has policies for safely managing undeliverable packages that might include drugs;

(iv) If transporter delivered covered drugs to the wrong address, description of attempts to retrieve covered drugs and whether those attempts were successful;

(v) Program operator actions to ensure problem was reported, if required; appropriate investigation occurred; and risk of similar problem occurring in the future was minimized; and

(vi) Changes to policies, procedures, or tracking mechanisms to address the problem and improve safety and security.

(k) A description of public education, outreach, and evaluation activities implemented and shall include the following. "Promotional material" shall have the same definition as in WAC 246-480-070(4):

(i) List of languages that printed or downloadable public promotional material are available in, with description of any printed or downloadable promotional material not available in these languages. List or description of languages used in any television, radio, social media, or other nonprint promotional material;

(ii) List or description of languages available on the single website and program operator specific website; the single toll-free telephone number and program operator specific telephone number; and call centers associated with the single toll-free telephone number and program operator specific telephone number. This list or description must include the name of language service providers where applicable;

(iii) Description of how these languages or language services meet the language needs of people in Washington;

(iv) Copies of all public promotional material, including signage and changes to websites and telephone number scripts, developed since last annual report;

(v) Description of how education and outreach efforts were implemented including:

(A) Date, type, and description of all social media and email promotion activity;

(B) Date, frequency, reach, and description of outreach for radio, television, print, and digital media platforms;

(C) List of brochures and posters available from single website and program operator specific website, number of times each was viewed, and number of times each was downloaded;

(D) Name, address, facility type, and date of email or hard copy distribution of brochures and posters to nonresidential entities; and

(E) Total number of views and number of unique visitors for each page of single website and program operator specific website.

(vi) Description of evaluation activities shall include:

(A) Evaluation of comments, questions, and concerns received from the public including evaluation of feedback themes and actions program operator has implemented or planned in response to feedback; and

(B) Evaluation of public education and outreach efforts, including evaluation of education and outreach implementation described in (g)(v) of this subsection.

(l) A description of how collected packaging was recycled to the extent feasible.

(m) A summary of the program's goals for collection amounts and public awareness shall include:

(i) Description of goals for the reporting year;

(ii) Description of goals for the following year, including identification of any unmet goals carried forward; and

(iii) Description of how program operator calculates or quantifies progress toward goals, including any percentages included in goals.

(n) A summary of degree of success in meeting goals shall include description of why goals were not met and what effort program operator will make to achieve those goals the following year.

(o) The program's annual expenditures, itemized by program category shall be organized using the criteria described in WAC 246-480-040(5).

(1) Consistent with RCW 69.48.170, chapter 42.56 RCW, and other applicable laws, proprietary information submitted to the department under chapter 69.48 RCW is exempt from public disclosure. The manufacturer or drug take-back organization must identify in writing the information it considers proprietary when submitting information to the department. Information automatically disclosable under law may not be marked proprietary. Information not deemed automatically disclosable cannot be marked as proprietary in their entirety.

(2) If the department receives a request for disclosure under chapter 42.56 RCW which includes information identified by the manufacturer or drug take-back organization as proprietary, the department will notify the manufacturer or drug take-back organization of the status of such documents prior to their release. The manufacturer or drug take-back organization may seek to enjoin the release of the information as provided under RCW 42.56.540.

(1) Until January 1, 2024, a potential program operator applicant submitting a proposal in accordance with RCW 69.48.050(8) shall submit a nonrefundable proposal review fee of $157,000 to the department when they submit their proposal.

(2) After January 1, 2024, a potential program operator applicant shall submit a nonrefundable proposal review fee of $63,000 to the department when they submit their proposal in accordance with RCW 69.48.050(1). Approved program operators submitting updated proposals to the department do not submit a proposal review fee.

(3) All program operators' annual operating fees shall be identical. Each program operator's annual operating fee shall not exceed the lesser of:

(a) The department's estimated actual administrative, oversight, enforcement, and contractual costs for that fiscal year divided by the number of approved program operators; or

(b) Ten percent of the lowest annual expenditures reported to the department in any program operator's annual report and determined by the department.

(4) Annually, on or before September 1st, the department shall notify each program operator the amount of the program operator's annual operating fee.

(5) Each program operator shall submit their annual operating fee to the department by October 1st each year.